Evolus, Inc. (0K16.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Evolus, Inc.
Address
520 Newport Center Drive
Newport Beach, CA 92660
United States of America (the)
Phone
949 284 4555
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
372
First IPO Date
August 03, 2018
Key Executives
| Name | Title | Pay | Year Born |
| David Moatazedi | President, Chief Executive Officer & Director | 1.23M | 1978 |
| Tatjana Mitchell | Chief Financial Officer | 711,398 | N/A |
| Rui Avelar C.CFP Dip.SportMed | Chief Medical Officer and Head of Research & Development | 730,167 | 1962 |
| Jeffrey J. Plumer | Corporate Secretary | 0 | N/A |
| Kurt Knab | Senior Vice President of Sales | 0 | N/A |
| Nareg Sagherian | Head of Global Investor Relations & Corporate Communications | 0 | N/A |
| Jessica Novak | Senior Vice President of Human Resources | 0 | N/A |
AD
Description
Evolus, Inc. functions as a performance beauty specialist, supplying medical aesthetic solutions to healthcare practitioners and their patients across the United States. Central to its offerings is Jeuveau, an exclusive formulation of 900 kilodalton purified botulinum toxin type A. This product is specifically engineered to offer a temporary improvement in the appearance of moderate to severe frown lines in adults. The firm was established in 2012 and maintains its primary office in Newport Beach, California.
AD
